Patents by Inventor Roger Thomas Palframan

Roger Thomas Palframan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTI-SPECIFIC ANTIBODIES AND ANTIBODY COMBINATIONS
    Publication number: 20240067758
    Abstract: The present invention relates to antibodies binding to IL13 and IL22. The invention provides novel multi-specific antibodies that bind to both IL13 and IL22 and compositions comprising an antibody that binds to IL13 and an antibody that binds to IL22. The invention further relates to therapeutic uses of the combination of anti-IL13 and anti-IL22 antibodies and multi-specific antibodies that bind to both IL13 and IL22.
    Type: Application
    Filed: December 6, 2021
    Publication date: February 29, 2024
    Inventors: Joseph Michael David RASTRICK, John Paul SILVA, Daniel John LIGHTWOOD, Ralph ADAMS, Roger Thomas PALFRAMAN, Kerry Louise TYSON, Peter Charles ELLIOTT, Seema MAYANK, Andrea Julie CROSBY, Emily Mary Cairistine BARRY, Seppe Frans Roman LEYSEN, Zainab AHDASH
  • ANTIBODY WITH BINDING SPECIFICITY FOR HUMAN IL-13
    Publication number: 20230084464
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing the antibody molecules.
    Type: Application
    Filed: December 18, 2020
    Publication date: March 16, 2023
    Inventors: Daniel John Lightwood, Ralph Adams, Roger Thomas Palframan
  • Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13
    Patent number: 9957320
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing antibody molecules.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: May 1, 2018
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Neil Gozzard, Alastair David Griffiths Lawson, Daniel John Lightwood, Roger Thomas Palframan, Bryan John Smith, Kerry Louise Tyson
  • ANTIBODY MOLECULES HAVING BINDING SPECIFICITY FOR HUMAN IL-13
    Publication number: 20160289323
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: June 13, 2016
    Publication date: October 6, 2016
    Inventors: Neil Gozzard, Alastair David Griffiths Lawson, Daniel John Lightwood, Roger Thomas Palframan, Bryan John Smith, Kerry Louise Tyson
  • Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13
    Patent number: 9394361
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing antibody molecules.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: July 19, 2016
    Assignee: UCB BIOPHARMA SPRL
    Inventors: Neil Gozzard, Alastair David Griffiths Lawson, Daniel John Lightwood, Roger Thomas Palframan, Bryan John Smith, Kerry Louise Tyson
  • ANTIBODY MOLECULES HAVING BINDING SPECIFICITY FOR HUMAN IL-13
    Publication number: 20140178387
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: February 21, 2014
    Publication date: June 26, 2014
    Applicant: UCB Pharma S.A.
    Inventors: NEIL GOZZARD, ALASTAIR DAVID GRIFFITHS LAWSON, DANIEL JOHN LIGHTWOOD, ROGER THOMAS PALFRAMAN, BRYAN JOHN SMITH, KERRY LOUISE TYSON
  • Antibody molecules having binding specificity for human IL-13
    Patent number: 8691233
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: April 8, 2014
    Assignee: UCB Pharma S.A.
    Inventors: Neil Gozzard, Alastair David Griffiths Lawson, Daniel John Lightwood, Roger Thomas Palframan, Bryan John Smith, Kerry Louise Tyson
  • ANTIBODY MOLECULES HAVING BINDING SPECIFICITY FOR HUMAN IL-13
    Publication number: 20100260773
    Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
    Type: Application
    Filed: March 10, 2010
    Publication date: October 14, 2010
    Inventors: Neil Gozzard, Alastair David Griffiths Lawson, Daniel John Lightwood, Roger Thomas Palframan, Bryan John Smith, Kerry Louise Tyson